Chemoinformaics analysis of 9-Decen-2-one, 5-methylene-
Molecular Weight | 166.264 | nRot | 7 |
Heavy Atom Molecular Weight | 148.12 | nRig | 3 |
Exact Molecular Weight | 166.136 | nRing | 0 |
Solubility: LogS | -2.283 | nHRing | 0 |
Solubility: LogP | 2.173 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 31.1743 |
nHD | 0 | BPOL | 18.9257 |
QED | 0.419 |
Synth | 2.746 |
Natural Product Likeliness | 1.67 |
NR-PPAR-gamma | 0.015 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.029 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.483 |
MDCK | 0.0000212 |
BBB | 0.992 |
PPB | 0.76914 |
VDSS | 0.856 |
FU | 0.152083 |
CYP1A2-inh | 0.316 |
CYP1A2-sub | 0.816 |
CYP2c19-inh | 0.135 |
CYP2c19-sub | 0.695 |
CYP2c9-inh | 0.042 |
CYP2c9-sub | 0.768 |
CYP2d6-inh | 0.024 |
CYP2d6-sub | 0.916 |
CYP3a4-inh | 0.096 |
CYP3a4-sub | 0.224 |
CL | 7.005 |
T12 | 0.826 |
hERG | 0.01 |
Ames | 0.013 |
ROA | 0.02 |
SkinSen | 0.447 |
Carcinogencity | 0.745 |
EI | 0.978 |
Respiratory | 0.138 |
NR-Aromatase | 0.008 |
Antiviral | No |
Prediction | 0.833432 |